[{"NetIncomeLoss_3_Q3_USD":803946000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":11116196000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":50732000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":131596000.0,"FinancingReceivableAllowanceForCreditLossesRecovery_3_Q3_USD":457009000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":333622000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":531380000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q3_USD":1159657000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent_3_Q3_USD":4066000.0,"EquityMethodInvestments_0_Q3_USD":439839000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesNetOfTax_3_Q3_USD":24022000.0,"Liabilities_0_Q3_USD":6192030000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1552802000.0,"OtherAssetsNoncurrent_0_Q3_USD":4891000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":5796000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":17262000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":15064000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":3768000.0,"DerivativeLiabilitiesCurrent_0_Q3_USD":0.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_3_Q3_USD":4066000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":11891030000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":0.0,"OtherNoncashIncomeExpense_3_Q3_USD":-8163000.0,"LongTermDebtCurrent_0_Q3_USD":0.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":3000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":3000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":294435000.0,"AssetsCurrent_0_Q3_USD":2783851000.0,"NotesAndLoansReceivableNetNoncurrent_0_Q3_USD":11927576000.0,"ProvisionForLoanLossesExpensed_3_Q3_USD":138747000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":1908474000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1926918000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":34746000.0,"InterestPaidNet_3_Q3_USD":102429000.0,"FinancingReceivableAllowanceForCreditLossesWriteOffs_3_Q3_USD":494258000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":24388000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_1_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":860193000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":324104000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-23337000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-29000000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-30272000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":370002000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":367756000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q3_USD":160226000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q3_USD":200955000.0,"MinorityInterest_0_Q3_USD":5346835000.0,"EarningsPerShareBasic_1_Q3_USD":0.79,"EarningsPerShareBasic_3_Q3_USD":0.88,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":571754000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":5096000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":18510000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-44770000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_3_Q3_USD":52181000.0,"EquityMethodInvestmentDividendsOrDistributions_3_Q3_USD":36041000.0,"Revenues_3_Q3_USD":1550210000.0,"OtherAssetsCurrent_0_Q3_USD":14398000.0,"IncreaseDecreaseInFinanceReceivables_3_Q3_USD":1435536000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":609604000.0,"NotesReceivableNet_0_Q3_USD":12484432000.0,"DerivativeAssetsNoncurrent_0_Q3_USD":7629000.0,"CostsAndExpenses_1_Q3_USD":27832000.0,"CostsAndExpenses_3_Q3_USD":268866000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":290632000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1764565000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":11404000.0,"FinancingReceivableChangeInPresentValueExpenseReversal_3_Q3_USD":2964000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_3_Q3_USD":1177000.0,"InvestmentIncomeNet_1_Q3_USD":1587000.0,"InvestmentIncomeNet_3_Q3_USD":7169000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":155019000.0,"Revenues_1_Q3_USD":538399000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":12935000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q3_USD":175348000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_3_Q3_USD":865032000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":135595000.0,"TradingSecuritiesDebt_0_Q3_USD":579527000.0,"DividendsCash_1_Q3_USD":54885000.0,"DividendsCash_3_Q3_USD":54885000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":369999000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":367753000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1468956000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":624254000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":1335326000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":73405000.0,"PaymentsToAcquireFinanceReceivables_3_Q3_USD":1377085000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":13743000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":33961000.0,"NotesReceivableGross_0_Q3_USD":13644089000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":29262000.0,"LiabilitiesCurrent_0_Q3_USD":269983000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":46564000.0,"NonoperatingIncomeExpense_3_Q3_USD":53982000.0,"NonoperatingIncomeExpense_1_Q3_USD":113687000.0,"NetIncomeLoss_1_Q3_USD":290632000.0,"ProvisionForLoanAndLeaseLosses_3_Q3_USD":101498000.0,"ProvisionForLoanAndLeaseLosses_1_Q3_USD":-33792000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":34462000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":9798648000.0,"NotesAndLoansReceivableNetCurrent_0_Q3_USD":556856000.0,"AdditionalPaidInCapital_0_Q3_USD":2611976000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":1095259000.0,"ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_3_Q3_USD":15084000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":324104000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q3_USD":858000.0,"LongTermDebtNoncurrent_0_Q3_USD":5812047000.0,"IncreaseDecreaseInOtherReceivables_3_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":1552802000.0,"InterestExpense_1_Q3_USD":31444000.0,"InterestExpense_3_Q3_USD":119217000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":290632000.0,"IncreaseDecreaseInDerivativeLiabilities_3_Q3_USD":-34952000.0,"EarningsPerShareDiluted_1_Q3_USD":0.79,"EarningsPerShareDiluted_3_Q3_USD":0.88,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_3_Q3_USD":428000.0,"ShareBasedCompensation_3_Q3_USD":4588000.0,"StockholdersEquityOther_3_Q3_USD":0.0,"StockholdersEquityOther_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":7571000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":71311000.0,"Assets_0_Q3_USD":15990678000.0,"OperatingIncomeLoss_3_Q3_USD":1281344000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":198526000.0,"GainLossOnDerivativeInstrumentsNetPretax_1_Q3_USD":-7088000.0,"GainLossOnDerivativeInstrumentsNetPretax_3_Q3_USD":-39886000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":7571000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":67245000.0,"TreasuryStockValue_0_Q3_USD":2155000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":848000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":4588000.0,"ProceedsFromInterestReceived_3_Q3_USD":7476000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":298203000.0,"OperatingIncomeLoss_1_Q3_USD":510567000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":43507000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":1306603000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":1807146000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":6869000.0,"TransferOfInvestments_3_Q3_USD":303679000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":125121000.0,"UnrealizedGainLossOnDerivatives_3_Q3_USD":-39886000.0,"PaymentsToMinorityShareholders_3_Q3_USD":400893000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":110000000.0,"ProfitLoss_1_Q3_USD":624254000.0,"DerivativeLiabilitiesNoncurrent_0_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4700000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":15990678000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":606216000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":1909651000.0,"ProfitLoss_3_Q3_USD":1335326000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":875257000.0,"Ticker":"RPRX","CIK":"1802768","name":"ROYALTY PHARMA PLC","OfficialName":"Royalty Pharma plc Class A Ordinary Shares ","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"19213987432.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]